Dr. Lacouture on Dermatologist Communication

Video

Mario E. Lacouture, MD, dermatologist, Memorial Sloan-Kettering Cancer Center, explains the challenges that need to be overcome to improve communication between oncologists and dermatologists.

Mario E. Lacouture, MD, dermatologist, Memorial Sloan-Kettering Cancer Center, explains the challenges that need to be overcome to improve communication between oncologists and dermatologists.

Lacouture says that one of the major challenges stems from an overall lack of dermatologists. As a result, only 8% of patients who develop a dermatologic side effect will actually see a dermatologist during therapy.

The timing of communication is important as oncologists need to quickly judge whether or not to continue with therapy. At the initial referral to a dermatologist, the oncologist needs to provide information about duration of treatment and type of therapy. This can be used to more accurately determine the cause of the adverse event.

Dermatologists and oncologists have different systems for grading side effects in patients. To provide an accurate classification of adverse events, dermatologists must be aware of the language and terminology used by oncologists.

Related Videos
Shivaani Kummar, MBBS, FACP, Margaret and Lester DeArmond Endowed Chair of Cancer Research, Professor and Division Head, Division of Hematology/Medical Oncology, Oregon Health & Science University School of Medicine; co-director, Center for Experimental Therapeutics, co-deputy director, Knight Cancer Institute
Andre Goy, MD
Wenxin (Vincent) Xu, MD,
Guenther Koehne, MD, PhD
Alessandro Villa, DDS, PhD, MPH
Joseph Mikhael, MD
Michael Richardson, MD
Minesh Mehta, MD
Ruben Olivares, MD
Phillip J. Koo, MD